Details for New Drug Application (NDA): 050711

« Back to Dashboard

NDA 050711 describes ZITHROMAX, which is a drug marketed by Pfizer and is included in seven NDAs. It is available from thirteen suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ZITHROMAX profile page.

The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the azithromycin profile page.

Summary for 050711

Tradename:	ZITHROMAX
Applicant:	Pfizer
Ingredient:	azithromycin
Patents:	1
Formulation / Manufacturing:	see details

Pharmacology for NDA: 050711

Medical Subject Heading (MeSH) Categories for 050711

Anti-Bacterial Agents

Suppliers and Packaging for NDA: 050711

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZITHROMAX	azithromycin	TABLET;ORAL	050711	NDA	Pfizer Laboratories Div Pfizer Inc	0069-3060	0069-3060-30	30 TABLET, FILM COATED in 1 BOTTLE (0069-3060-30)
ZITHROMAX	azithromycin	TABLET;ORAL	050711	NDA	Pfizer Laboratories Div Pfizer Inc	0069-3060	0069-3060-75	3 BLISTER PACK in 1 BOX (0069-3060-75) > 6 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 250MG BASE
Approval Date:	Jul 18, 1996	TE:	AB	RLD:	Yes
Patent:	➤ Sign Up	Patent Expiration:	Jul 31, 2018	Product Flag?		Substance Flag?	Y	Delist Request?

Expired US Patents for NDA 050711

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	ZITHROMAX	azithromycin	TABLET;ORAL	050711-001	Jul 18, 1996	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.